| Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma RA Vaubel, S Tian, D Remonde, MA Schroeder, AC Mladek, GJ Kitange, ... Clinical Cancer Research 26 (5), 1094-1104, 2020 | 172 | 2020 |
| Molecular profiling of long-term IDH-wildtype glioblastoma survivors DM Burgenske, J Yang, PA Decker, TM Kollmeyer, ML Kosel, AC Mladek, ... Neuro-oncology 21 (11), 1458-1469, 2019 | 73 | 2019 |
| GENE-28. CLINICAL AND MOLECULAR ANALYSES OF LONG-TERM SURVIVORS OF GLIOBLASTOMA D Burgenske, J Eckel-Passow, P Decker, M Kosel, R Youland, ... Neuro-Oncology 19 (Suppl 6), vi98, 2017 | 1 | 2017 |
| TMOD-18. THE PATIENT DERIVED XENOGRAFT NATIONAL RESOURCE: A COMPREHENSIVE COLLECTION OF HIGH-GRADE GLIOMA MODELS FOR PRE-CLINICAL AND TRANSLATIONAL STUDIES R Vaubel, S Tian, D Remonde, M Schroeder, T Kollmeyer, S Peng, ... Neuro-Oncology 20 (suppl_6), vi272-vi272, 2018 | | 2018 |
| Experimental design recommendations for PDX pre-clinical trials: Reanalysis of radiation and temozolomide orthotopic survival data in GBM models J Sarkaria, P Decker, D Remonde, M Kosel, B Carlson, M Schroeder, ... European Journal of Cancer 1 (69), S58, 2016 | | 2016 |
| GENO-37 Molecular profiling of long-term survivors of glioblastoma R Youland, D Remonde, A Caron, A Mladek, P Decker, H Sicotte, ... Neuro-oncology 17 (suppl_5), v100-v100, 2015 | | 2015 |
| Characterization of patient-derived xenograft (PDX) models to evaluate clinical and therapeutic responses of glioblastoma multiforme DA Remonde, BL Carlson, MA Schroeder, B Armstrong, S Peng, L Evers, ... Cancer Research 75 (15_Supplement), 1468-1468, 2015 | | 2015 |
